BG Medicine, Inc. 4
4 · BG Medicine, Inc. · Filed May 4, 2016
Insider Transaction Report
Form 4
Adourian Aram S.
VP, Scientific Affairs
Transactions
- Exercise/Conversion
Common Stock
2014-04-14$0.90/sh+12,000$10,800→ 40,036 total - Exercise/Conversion
Stock Option (right to buy)
2014-04-14−12,000→ 16,036 totalExercise: $0.90Exp: 2014-04-15→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]The reporting person paid cash for the exercise price. The share and exercise price figures in this report do not reflect the 1-for-4 reverse stock split of the issuer's common stock effected on July 8, 2015.
- [F2]All of the shares underlying this option were vested and the option expired on April 15, 2014.